Income Taxes - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Operating Loss Carryforwards [Line Items]
R&D tax credit	$ 13,002	$ 9,747
Deferred tax assets, valuation allowance	48,662	50,536
Increase (decrease) in valuation allowance	(1,900)	$ (4,500)	$ 5,100
Cernostics, Inc. and AltheaDx, Inc.
Operating Loss Carryforwards [Line Items]
NOLs acquired, subject to expiration	36,300
Capsulomics
Operating Loss Carryforwards [Line Items]
NOL carryforwards, not subject to expiration	2,300
NOLs acquired, subject to expiration	0
Domestic Tax Jurisdiction
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	134,800
NOL carryforwards, subject to expiration	52,900
NOL carryforwards, not subject to expiration	81,900
State and Local Jurisdiction
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	113,000
R&D tax credit	$ 1,400